BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
76.80
-0.56 (-0.72%)
At close: Nov 17, 2026, 4:00 PM EST
76.76
-0.04 (-0.05%)
After-hours: Nov 17, 2026, 5:52 PM EST
BridgeBio Pharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $88 → $91 | Buy | Maintains | $88 → $91 | +18.49% | Nov 13, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $106 → $108 | Buy | Maintains | $106 → $108 | +40.63% | Nov 2, 2026 |
| Barclays | Barclays | Buy Maintains $156 | Buy | Maintains | $156 | +103.13% | Nov 2, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Oct 30, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $100 | Buy | Maintains | $100 | +30.21% | Oct 30, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $110 → $100 | Buy | Maintains | $110 → $100 | +30.21% | Oct 30, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $110 | Buy | Reiterates | $110 | +43.23% | Oct 30, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $130 | Buy | Maintains | $130 | +69.27% | Oct 30, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.